Adaptive decision support for addiction treatment to implement initiation of buprenorphine for opioid use disorder in the emergency department: protocol for the ADAPT Multiphase Optimization Strategy trial
Authors
Daniel F. Sarpong (ORCID: https://orcid.org/0000-0003-2094-3041)
F. Perry Wilson (ORCID: https://orcid.org/0000-0002-2633-2412)
Laurel Buchanan
Carol Oladele (ORCID: https://orcid.org/0000-0002-1154-8974)
Jason Hoppe (ORCID: https://orcid.org/0000-0002-3396-6907)
Georgia Clinical and Translational Science Alliance
National Institutes of Health
National Institute on Drug Abuse
National Center for Advancing Translational Sciences
Controls
|||
ALL TIME
JAN
FEB
MAR
APR
MAY
JUN
JUL
AUG
SEP
OCT
article
Adaptive decision support for addiction treatment to implement initiation of buprenorphine for opioid use disorder in the emergency department: protocol for the ADAPT Multiphase Optimization Strategy trial
Daniel F. Sarpong, F. Perry Wilson, Laurel Buchanan, Carol Oladele et al.
Citations
2 citations
Journal
BMJ Open
Topics
Opioid Use Disorder Treatment
Field-Weighted Citation Impact (FWCI)
3.76
article
Adaptive decision support for addiction treatment to implement initiation of buprenorphine for opioid use disorder in the emergency department: protocol for the ADAPT Multiphase Optimization Strategy trial
Daniel F. Sarpong, F. Perry Wilson, Laurel Buchanan, Carol Oladele, Jason Hoppe, Gail D’Onofrio, Hyung Paek, Mark Iscoe, M. Kit Delgado, Patrick J. Heagerty, James D Dziura, Deborah R Levy, Edward R. Melnick, Catalina Hooper, Daniella Meeker, Richard A. Taylor
article en
2 citations
Abstract
No abstract available for this paper.
Publication Tag
BMJ OpenVol. 15(2)
Institutions
University of Washington (US), Yale University (US), VA Connecticut Healthcare System (US), Yale New Haven Health System (US), University of Pennsylvania (US), University of Colorado Denver (US)
Funders
U.S. Department of Veterans Affairs, Office of Research and Development, Georgia Clinical and Translational Science Alliance, National Institutes of Health, National Institute on Drug Abuse, National Center for Advancing Translational Sciences